세계의 의약품용 화학제품 시장 규모 조사: 제품별, 용도별 및 지역별 예측(2022-2032년)

Global Pharmaceutical Chemicals Market is valued approximately at USD 115.24 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 6.7% over the forecast period 2024-2032. Pharmaceutical chemicals are specialized chemical compounds used in the creation, development, and manufacturing of pharmaceutical products. These chemicals include active pharmaceutical ingredients (APIs), which are the biologically active components responsible for the therapeutic effects of medications, as well as excipients, which are inactive substances that serve as carriers or stabilizers for the APIs. Pharmaceutical chemicals are essential at various stages of drug development, from initial research and development to large-scale production. They must meet stringent quality and purity standards set by regulatory bodies to ensure the safety and efficacy of the medications. The production of pharmaceutical chemicals involves complex processes, including chemical synthesis, fermentation, and biotechnological methods. Advances in chemical engineering and pharmaceutical sciences continue to drive innovation in this field, enabling the development of new and more effective treatments for a wide range of medical conditions.

The pharmaceutical chemicals market is poised for substantial growth, driven by the increasing demand for advanced drugs and active pharmaceutical ingredients (APIs). The rising prevalence of chronic diseases globally is a significant factor contributing to the market expansion, necessitating the development and production of innovative pharmaceutical solutions. The market's expansion is further fueled by emerging applications of pharmaceutical chemicals, presenting lucrative opportunities for industry players. The continuous development of new pharmaceutical drugs, coupled with evolving markets, are key trends expected to boost market growth. Additionally, increasing healthcare expenditure in emerging markets is influencing global business strategies, with a focus on health concerns and advanced product launches. Moreover, the rising demand for advanced drugs, an aging population, the growing need for active pharmaceutical ingredients, the development of neurological drugs, accessible healthcare insurance, and government support for R&D activities are further fostering the market growth. However, stringent regulatory requirements and high manufacturing costs would stifle the market growth.

The key regions considered for the Global Pharmaceutical Chemicals Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America maintained the highest market share in 2022, driven by supportive government policies and extensive R&D activities. Moreover, favorable government mandates and robust research and development activities in pharmaceutical chemical production is fostering the market growth in the region. Conversely, the Asia-Pacific region is expected to exhibit the fastest growth rate from 2024 to 2032, propelled by increasing API production and significant investments in the R&D sector by key market players. The burgeoning population and rising incidence of chronic diseases further amplify the demand for pharmaceutical chemicals in this region.

Major market players included in this report are:

• BASF SE
• Lonza Group AG
• Boehringer Ingelheim GmbH
• Merck KGaA
• Evonik Industries AG
• Johnson Matthey Plc
• Thermo Fisher Scientific Inc.
• AbbVie Inc.
• Catalent, Inc.
• Pfizer Inc.
• Hoffmann-La Roche AG
• Sanofi S.A.
• Novartis International AG
• GlaxoSmithKline plc (GSK)
• Sun Pharmaceutical Industries Ltd.

The detailed segments and sub-segment of the market are explained below:

By Product:

• Basic Building Blocks
• Advanced Intermediates
• Active Ingredients

By Application:

• Cardiovascular
• Neurology
• Oncology
• Infectious Diseases
• Metabolic System
• Diabetes
• Respiratory Diseases
• Gastrointestinal Diseases
• Musculoskeletal Diseases
• Other

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• Rest of Asia Pacific
• Latin America
• Brazil
• Mexico
• Rest of Latin America
• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Years considered for the study are as follows:

• Historical year - 2022
• Base year - 2023
• Forecast period - 2024 to 2032

Key Takeaways:

• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global Pharmaceutical Chemicals Market Executive Summary

• 1.1. Global Pharmaceutical Chemicals Market Size & Forecast (2022-2032)
• 1.2. Regional Summary
• 1.3. Segmental Summary
  • 1.3.1. By Product
  • 1.3.2. By Application
• 1.4. Key Trends
• 1.5. Recession Impact
• 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Pharmaceutical Chemicals Market Definition and Research Assumptions

• 2.1. Research Objective
• 2.2. Market Definition
• 2.3. Research Assumptions
  • 2.3.1. Inclusion & Exclusion
  • 2.3.2. Limitations
  • 2.3.3. Supply Side Analysis
    • 2.3.3.1. Availability
    • 2.3.3.2. Infrastructure
    • 2.3.3.3. Regulatory Environment
    • 2.3.3.4. Market Competition
    • 2.3.3.5. Economic Viability (Consumer's Perspective)
  • 2.3.4. Demand Side Analysis
    • 2.3.4.1. Regulatory Frameworks
    • 2.3.4.2. Technological Advancements
    • 2.3.4.3. Environmental Considerations
    • 2.3.4.4. Consumer Awareness & Acceptance
• 2.4. Estimation Methodology
• 2.5. Years Considered for the Study
• 2.6. Currency Conversion Rates

Chapter 3. Global Pharmaceutical Chemicals Market Dynamics

• 3.1. Market Drivers
  • 3.1.1. Rising Demand for Advanced Drugs
  • 3.1.2. Growing Geriatric Population
  • 3.1.3. Increasing Demand for Active Pharmaceutical Ingredients
• 3.2. Market Challenges
  • 3.2.1. Stringent Regulatory Requirements
  • 3.2.2. High Manufacturing Costs
• 3.3. Market Opportunities
  • 3.3.1. Advancements in Drug Development
  • 3.3.2. Expansion in Emerging Markets
  • 3.3.3. Increasing Healthcare Expenditure

Chapter 4. Global Pharmaceutical Chemicals Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
  • 4.1.6. Futuristic Approach to Porter's 5 Force Model
  • 4.1.7. Porter's 5 Force Impact Analysis
• 4.2. PESTEL Analysis
  • 4.2.1. Political
  • 4.2.2. Economical
  • 4.2.3. Social
  • 4.2.4. Technological
  • 4.2.5. Environmental
  • 4.2.6. Legal
• 4.3. Top investment opportunity
• 4.4. Top winning strategies
• 4.5. Disruptive Trends
• 4.6. Industry Expert Perspective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Pharmaceutical Chemicals Market Size & Forecasts by Product 2022-2032

• 5.1. Segment Dashboard
• 5.2. Global Pharmaceutical Chemicals Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 5.2.1. Basic Building Blocks
  • 5.2.2. Advanced Intermediates
  • 5.2.3. Active Ingredients

Chapter 6. Global Pharmaceutical Chemicals Market Size & Forecasts by Application 2022-2032

• 6.1. Segment Dashboard
• 6.2. Global Pharmaceutical Chemicals Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 6.2.1. Cardiovascular
  • 6.2.2. Neurology
  • 6.2.3. Oncology
  • 6.2.4. Infectious Diseases
  • 6.2.5. Metabolic System
  • 6.2.6. Diabetes
  • 6.2.7. Respiratory Diseases
  • 6.2.8. Gastrointestinal Diseases
  • 6.2.9. Musculoskeletal Diseases
  • 6.2.10. Other

Chapter 7. Global Pharmaceutical Chemicals Market Size & Forecasts by Region 2022-2032

• 7.1. North America Pharmaceutical Chemicals Market
  • 7.1.1. U.S. Pharmaceutical Chemicals Market
    • 7.1.1.1. Product breakdown size & forecasts, 2022-2032
    • 7.1.1.2. Application breakdown size & forecasts, 2022-2032
  • 7.1.2. Canada Pharmaceutical Chemicals Market
• 7.2. Europe Pharmaceutical Chemicals Market
  • 7.2.1. UK Pharmaceutical Chemicals Market
  • 7.2.2. Germany Pharmaceutical Chemicals Market
  • 7.2.3. France Pharmaceutical Chemicals Market
  • 7.2.4. Spain Pharmaceutical Chemicals Market
  • 7.2.5. Italy Pharmaceutical Chemicals Market
  • 7.2.6. Rest of Europe Pharmaceutical Chemicals Market
• 7.3. Asia-Pacific Pharmaceutical Chemicals Market
  • 7.3.1. China Pharmaceutical Chemicals Market
  • 7.3.2. India Pharmaceutical Chemicals Market
  • 7.3.3. Japan Pharmaceutical Chemicals Market
  • 7.3.4. Australia Pharmaceutical Chemicals Market
  • 7.3.5. South Korea Pharmaceutical Chemicals Market
  • 7.3.6. Rest of Asia Pacific Pharmaceutical Chemicals Market
• 7.4. Latin America Pharmaceutical Chemicals Market
  • 7.4.1. Brazil Pharmaceutical Chemicals Market
  • 7.4.2. Mexico Pharmaceutical Chemicals Market
  • 7.4.3. Rest of Latin America Pharmaceutical Chemicals Market
• 7.5. Middle East & Africa Pharmaceutical Chemicals Market
  • 7.5.1. Saudi Arabia Pharmaceutical Chemicals Market
  • 7.5.2. South Africa Pharmaceutical Chemicals Market
  • 7.5.3. Rest of Middle East & Africa Pharmaceutical Chemicals Market

Chapter 8. Competitive Intelligence

• 8.1. Key Company SWOT Analysis
• 8.2. Top Market Strategies
• 8.3. Company Profiles
  • 8.3.1. BASF SE
    • 8.3.1.1. Key Information
    • 8.3.1.2. Overview
    • 8.3.1.3. Financial (Subject to Data Availability)
    • 8.3.1.4. Product Summary
    • 8.3.1.5. Market Strategies
  • 8.3.2. Lonza Group AG
  • 8.3.3. Boehringer Ingelheim GmbH
  • 8.3.4. Merck KGaA
  • 8.3.5. Evonik Industries AG
  • 8.3.6. Johnson Matthey Plc
  • 8.3.7. Thermo Fisher Scientific Inc.
  • 8.3.8. AbbVie Inc.
  • 8.3.9. Catalent, Inc.
  • 8.3.10. Pfizer Inc.
  • 8.3.11. Hoffmann-La Roche AG
  • 8.3.12. Sanofi S.A.
  • 8.3.13. Novartis International AG
  • 8.3.14. GlaxoSmithKline plc (GSK)
  • 8.3.15. Sun Pharmaceutical Industries Ltd.

Chapter 9. Research Process

• 9.1. Research Process
  • 9.1.1. Data Mining
  • 9.1.2. Analysis
  • 9.1.3. Market Estimation
  • 9.1.4. Validation
  • 9.1.5. Publishing
• 9.2. Research Attributes